DNA and Gene Chips Market Size, Share, And Growth Report 2032

DNA and Gene Chips Market Size

The global DNA and Gene Chips market size was worth around USD 8.45 billion in 2023 and is predicted to grow to around USD 22.87 billion by 2032 with a compound annual growth rate (CAGR) of roughly 11.7% between 2024 and 2032.

The study provides historical data from 2018 to 2022 along with a forecast from 2024 to 2032 based on revenue (USD Billion). The report covers a forecast and an analysis of the DNA and Gene Chips market on a global and regional level.

Request Free Sample

DNA and Gene Chips Market: Overview

DNA and gene chips are also known as DNA microarrays. DNA microarrays are biochips that are used to detect a large number of genes,  which are present in a gene sample. DNA microarrays are microscopic slides that are made up of thousands of spots present in defined positions. These spots contain particular DNA sequences or DNA genes. This DNA sequence acts as a probe for gene detection and is mainly used to detect large DNA sequences.

According to the World Health Organization, cancer is the second leading cause of deaths worldwide. The growing prevalence of cancer worldwide is fueling the research activities for cancer treatment and diagnosis, which is the major growth driver of the global DNA and gene chips market. The rising number of research activities related to gene expression and drug discovery for the treatment of genetic diseases is also driving the global DNA and gene chips market. Increase in government funding for research activities, growth in the demand for personalized medicines, and an increase in the establishment of pharmaceutical companies in developing countries are other growth drivers of this market. However, the high cost of instruments and the dearth of skilled professionals may hinder the growth of the global DNA and gene chips market.

Request Free Sample

DNA and Gene Chips Market: Segmentation

The study provides a decisive view of the DNA and gene chips market on the basis of type, product, application, end-user, and region. All the segments have been analyzed based on present and future trends and the market is estimated from 2024 to 2032.

By type, the market for DNA and gene chips is bifurcated into oligonucleotide DNA and complementary DNA. Oligonucleotide DNA is anticipated to dominate the market in the future, owing to its high accuracy as compared to complementary DNA.

Based on the product, the DNA and gene chips market is fragmented into instruments and consumables. Consumables are predicted to dominate the DNA and gene chips market owing to the constant demand of the consumables because of the growing research activities.

Based on application, the DNA and gene chips market includes gene expression, cancer diagnosis and treatment, proteomics, drug discovery, genomics, agricultural biotechnology, and others. Drug discovery is projected to show a higher growth rate in the future, owing to the increase in research activities for drug development to treat chronic and genetic diseases.

Based on end-user, the market for DNA and gene chips includes hospital and diagnostic centers, academic and government research institutes, biotechnology and pharmaceutical companies, and others. Biotechnology and pharmaceutical companies are anticipated to show a high growth rate in the years ahead, owing to an increase in the establishment of manufacturing units, particularly in developing countries.

DNA and Gene Chips Market: Report Scope

DNA and Gene Chips Market: Regional Analysis

The regional segment includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa with its further bifurcation into major countries including the U.S., UK, Germany, France, China, Japan, India, Brazil, etc. 

By region, North America dominated the DNA and gene chips market globally in 2023, owing to the early introduction of highly developed research equipment, increase in healthcare spending, the presence of highly skilled workforce, and an increase in the number of R&D projects related to gene expression. The Asia Pacific is anticipated to show the highest year-to-year growth over the forecast time period, owing to the growing investments by government and companies for research activities related to the genome, the rising prevalence of cancer, and rapid technological advancements witnessed in the healthcare sector.

DNA and Gene Chips Market: Competitive Players

Some key players in the global DNA and gene chips market are:

• Perkin Elmer Inc.
• Illumina Inc.
• Thermo Fisher Scientific Inc.
• Macrogen Inc.
• Agilent Technologies
• Greiner Bio-One International GmbH
• Asper Biotech
• CapitalBio Corporation
• Microarrays Inc.
• Oxford Gene Technology
• Arrayit Corporation
• bioMérieux SA.

The Global DNA and Gene Chips Market is segmented as follows:

Global DNA and Gene Chips Market: Type Analysis

• Oligonucleotide DNA (o-DNA)
• Complementary DNA (c-DNA)

Global DNA and Gene Chips Market: Product Analysis

• Consumables
• Instruments

Global DNA and Gene Chips Market: Application Analysis

• Cancer Diagnosis and Treatment
• Gene Expression
• Proteomics
• Genomics
• Drug Discovery
• Agricultural Biotechnology
• Others

Global DNA and Gene Chips Market: End-User Analysis

• Academic and Government Research Institutes
• Hospitals and Diagnostics Centers
• Biotechnology and Pharmaceutical Companies
• Others

Global DNA and Gene Chips Market: Regional Analysis

• North America
  • The U.S.
• Europe
  • UK
  • France
  • Germany
• Asia Pacific
  • China
  • Japan
  • India
• Latin America
  • Brazil
• The Middle East and Africa